Accuray Incorporated
General ticker "ARAY" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $172.4M (TTM average)
Accuray Incorporated does not follow the US Stock Market performance with the rate: -1.1%.
Estimated limits based on current volatility of 3.0%: low 0.83$, high 0.89$
Factors to consider:
- Total employees count: 987 (-3.6%) as of 2024
- China accounted for 23.2% of revenue in the fiscal year ended 2024-06-30
- North and South America accounted for 20.2% of revenue in the fiscal year ended 2024-06-30
- Top business risk factors: Geopolitical risks, Currency fluctuations, Market acceptance, Manufacturing disruptions, Liquidity and credit risks
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-06-30 to 2027-06-30
- 2025-06-30 to 2026-06-30 estimated range: [0.87$, 1.99$]
- 2026-06-30 to 2027-06-30 estimated range: [1.07$, 2.32$]
Financial Metrics affecting the ARAY estimates:
- Positive: with PPE of -65.7 at the end of fiscal year the price was very low
- Positive: -5.02 < Operating profit margin, % of 1.71
- Negative: negative Industry operating cash flow (median)
- Negative: Return on assets ratio (scaled to [-100,100]) of -0.34 <= 1.77
- Negative: Industry earnings per price (median), % of -3.88 <= 0
- Negative: Investing cash flow per share per price, % of -6.41 <= -4.41
Short-term ARAY quotes
Long-term ARAY plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $447.61MM | $446.55MM | $458.50MM |
| Operating Expenses | $445.22MM | $446.05MM | $450.67MM |
| Operating Income | $2.38MM | $0.50MM | $7.84MM |
| Non-Operating Income | $-9.17MM | $-12.32MM | $-6.71MM |
| Interest Expense | $10.63MM | $11.62MM | $12.95MM |
| R&D Expense | $57.13MM | $49.73MM | $47.94MM |
| Income(Loss) | $-6.79MM | $-11.82MM | $1.13MM |
| Taxes | $2.49MM | $3.73MM | $2.73MM |
| Profit(Loss)* | $-9.28MM | $-15.54MM | $-1.59MM |
| Stockholders Equity | $53.66MM | $45.08MM | $81.17MM |
| Inventory | $145.15MM | $138.32MM | $141.02MM |
| Assets | $479.21MM | $468.63MM | $470.24MM |
| Operating Cash Flow | $15.54MM | $-11.90MM | $2.86MM |
| Capital expenditure | $12.68MM | $3.60MM | $8.52MM |
| Investing Cash Flow | $-12.68MM | $-3.60MM | $-8.52MM |
| Financing Cash Flow | $-2.11MM | $-3.95MM | $-4.25MM |
| Earnings Per Share** | $-0.10 | $-0.16 | $-0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.